EUVIMEDEUVIMED entdecken
Crossref

Mitotic Arrest Deficient 2 Like 1 Contributes to Colorectal Cancer Cell Migration, Invasion, and Oxaliplatin Resistance Through the Wnt/β‐Catenin Pathway

Xiang Ding, Yonggui Zhou, Linfang He, Hubin Kang, Youwu Wen, Jia Xu, Congbo Zhu, Libing Luo, Qingjun Zeng iD

Chemical Biology & Drug Design · 2024

DOI: 10.1111/cbdd.70012 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Chemical Biology & Drug Design, 2024. Verfasst von Xiang Ding und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology, Yueyang Central Hospital, Yueyang, Hunan, People's Republic of China. Hauptthemen laut MEDLINE: Oxaliplatin, Colorectal Neoplasms, Drug Resistance, Neoplasm, Wnt Signaling Pathway. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 20 Literaturangaben. Gefördert von: Scientific Research Project of Hunan Provincial Health Commission.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Colorectal cancer (CRC) is a highly prevalent malignancy, requiring chemotherapy for advanced stages of the disease. Previously, we found that mitotic arrest deficient 2 like 1 (MAD2L1) was upregulated and facilitated malignant proliferation in CRC. However, the association between MAD2L1 expression and tumor progression, as well as chemotherapy resistance in CRC, remains unclear. The progression capacities of CRC cells were assessed using transwell and wound healing assays, and the resistance to cisplatin in oxaliplatin‐resistant CRC cells was assessed using CCK‐8 assay and flow cytometry. Relevant protein levels of epithelial‐to‐mesenchymal transition (EMT) and Wnt/β‐catenin pathway were analyzed using western blotting. Revealing the impact of MAD2L1 on metastasis and drug resistance in CRC through inhibition of the Wnt/β‐catenin pathway. Knockdown of MAD2L1 attenuated the malignant progression of CRC cells, inhibited EMT, and blocked the Wnt/β‐catenin pathway. MAD2L1 was significantly upregulated in oxaliplatin‐resistant CRC cells, accompanied by the activation of the Wnt/β‐catenin pathway. Knockdown of MAD2L1 effectively reversed oxaliplatin resistance, leading to apoptosis and downregulation of the protein expression levels of β‐catenin, P‐glycoprotein (P‐gp), and ABCG2. After the knockdown of MAD2L1, the inhibition of the Wnt/β‐catenin pathway exhibited a synergistic effect, effectively suppressing malignant progression and reversing oxaliplatin resistance in CRC cells. So, knockdown of MAD2L1 suppressed cell malignant progression, equally sensitized resistant CRC cells to oxaliplatin, potentially by blocking the activation of the Wnt/β‐catenin pathway.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

OxaliplatinColorectal NeoplasmsDrug Resistance, NeoplasmWnt Signaling PathwayCell MovementEpithelial-Mesenchymal TransitionMad2 ProteinsHumansCell Line, TumorAntineoplastic Agentsbeta CateninOrganoplatinum Compounds

Stichwörter der Autor:innen

MAD2L1Wnt/β‐catenin signalingcolorectal cancermetastasisoxaliplatin resistance

Substanzen

OxaliplatinMad2 ProteinsMAD2L1 protein, humanAntineoplastic Agentsbeta CateninOrganoplatinum Compounds

Autor:innen und Institutionen

  • Department of Gastroenterology, Yueyang Central Hospital, Yueyang, Hunan, People's Republic of China.
  • Department of Gastrointestinal Surgery, Yueyang Central Hospital, Yueyang, Hunan, People's Republic of China.

ORCID-Profile: Qingjun Zeng

Förderung

  • Scientific Research Project of Hunan Provincial Health Commission

Zitieren

APA

Ding, X., Zhou, Y., He, L., Kang, H., Wen, Y., Xu, J., Zhu, C., Luo, L., & Zeng, Q. (2024). Mitotic Arrest Deficient 2 Like 1 Contributes to Colorectal Cancer Cell Migration, Invasion, and Oxaliplatin Resistance Through the Wnt/β‐Catenin Pathway. Chemical Biology & Drug Design. https://doi.org/10.1111/cbdd.70012

Vancouver

Ding X, Zhou Y, He L, Kang H, Wen Y, Xu J, et al. Mitotic Arrest Deficient 2 Like 1 Contributes to Colorectal Cancer Cell Migration, Invasion, and Oxaliplatin Resistance Through the Wnt/β‐Catenin Pathway. Chemical Biology & Drug Design. 2024. doi:10.1111/cbdd.70012

BibTeX
@article{Ding2024,
  author = {Ding, Xiang and Zhou, Yonggui and He, Linfang and Kang, Hubin and Wen, Youwu and Xu, Jia and Zhu, Congbo and Luo, Libing and Zeng, Qingjun},
  title = {Mitotic Arrest Deficient 2 Like 1 Contributes to Colorectal Cancer Cell Migration, Invasion, and Oxaliplatin Resistance Through the Wnt/β‐Catenin Pathway},
  journal = {Chemical Biology & Drug Design},
  year = {2024},
  doi = {10.1111/cbdd.70012}
}
Kostenlos starten →